Synlogic, Inc. (SYBX)
1.05
+0.05
(+5.00%)
USD |
OTCM |
Oct 23, 16:00
Synlogic Net Income (Quarterly) : -0.543M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.543M |
| March 31, 2026 | 0.681M |
| December 31, 2025 | 1.508M |
| September 30, 2025 | -2.301M |
| June 30, 2025 | -0.529M |
| March 31, 2025 | 0.317M |
| December 31, 2024 | -0.714M |
| September 30, 2024 | -0.117M |
| June 30, 2024 | 3.078M |
| March 31, 2024 | -25.61M |
| December 31, 2023 | -14.53M |
| September 30, 2023 | -12.08M |
| June 30, 2023 | -15.05M |
| March 31, 2023 | -15.62M |
| December 31, 2022 | -16.70M |
| September 30, 2022 | -17.91M |
| June 30, 2022 | -15.84M |
| March 31, 2022 | -15.70M |
| December 31, 2021 | -15.09M |
| September 30, 2021 | -16.02M |
| June 30, 2021 | -14.48M |
| March 31, 2021 | -14.97M |
| December 31, 2020 | -14.59M |
| September 30, 2020 | -13.22M |
| June 30, 2020 | -15.54M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.83M |
| December 31, 2019 | -12.80M |
| September 30, 2019 | -13.28M |
| June 30, 2019 | -12.34M |
| March 31, 2019 | -12.95M |
| December 31, 2018 | -11.93M |
| September 30, 2018 | -10.75M |
| June 30, 2018 | -14.59M |
| March 31, 2018 | -11.16M |
| December 31, 2017 | -11.70M |
| September 30, 2017 | -11.92M |
| June 30, 2017 | -9.388M |
| March 31, 2017 | -7.368M |
| December 31, 2016 | -6.848M |
| September 30, 2016 | -5.306M |
| June 30, 2016 | -5.638M |
| March 31, 2016 | -6.571M |
| December 31, 2015 | -8.789M |
| September 30, 2015 | -6.231M |
| June 30, 2015 | -5.684M |
| March 31, 2015 | -4.279M |
| December 31, 2014 | -4.378M |
| September 30, 2014 | -5.423M |
| June 30, 2014 | -2.997M |
| March 31, 2014 | -3.036M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.543M |
| EPS Diluted (Quarterly) | -0.0437 |
| Enterprise Value | -0.9016M |
| Earnings Yield | -4.45% |
| Normalized Earnings Yield | -19.20 |